FIELD: medicine, oncology, pharmacy. SUBSTANCE: invention proposes glyciphon ointment containing lanolin, Vaseline, emulsion waxes and methylphosphonic acid diglycidyl ester of the chemical formula: . Proposed drug shows the high selective antitumor activity, good cosmetic effect and absence of adverse responses. EFFECT: enhanced effectiveness of antitumor drug preparation. 2 cl, 3 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF INDUSTRIAL PRODUCTION OF STABLE PHARMACEUTICAL OINTMENT COMPOSITION | 2001 |
|
RU2202338C2 |
PREPARATION FOR TREATMENT OF SLUGGISH WOUND AND TROPHIC ULCER (VARIANTS) | 1998 |
|
RU2148989C1 |
METHOD OF TREATING PATIENTS WITH SKIN CANCER WITH NEOPLASTIC PROCESSES INVOLVING SKIN TISSUE, SUCH AS MELANOMA, BASAL CELL AND SQUAMOUS CELL CARCINOMA (VERSIONS) | 2014 |
|
RU2577135C2 |
METHOD FOR TREATING THE CASES OF NEUROTROPHIC NECROTIC TISSULAR DEFECTS | 2000 |
|
RU2197290C2 |
METHOD FOR TREATING PURULENT-INFLAMMATORY DISEASES OF SKIN AND SUBCUTANEOUS FIBER | 2001 |
|
RU2217065C2 |
DERIVATIVES OF 2-OXO-3,3,5-TRIMETHYL-1,2-OXAPHOSPHOLENE-4 SHOWING ANTIBLASTOMA ACTIVITY | 1990 |
|
SU1769528A1 |
METHOD FOR TREATMENT OF PATIENTS SUFFERING FROM CHRONIC OSTEOMYELITIS | 1992 |
|
RU2073514C1 |
METHOD FOR TREATING GASTROENTERIC TRACT WOUNDS | 1997 |
|
RU2159616C2 |
METHOD FOR PROPHYLACTIC TREATMENT IN CASE OFNEOPLASTIC PROCESSES INVOLVING SKIN TISSUE, SUCH AS MELANOMA, BASAL CELL AND SQUAMOUS CELL CARCINOMA | 2015 |
|
RU2619208C2 |
THERAPEUTIC AGENT FOR TREATMENT OF PRECANCEROUS SKIN LESIONS | 2004 |
|
RU2366447C2 |
Authors
Dates
2000-03-27—Published
1998-07-08—Filed